Concepedia
Statistics
Publications
6
Citations
442
H-Index
Active since
2001
Affiliations
AbbVie (United States)(Current)
Mayo Clinic in Arizona
WinnMed
University of California San Diego
Johns Hopkins University
Jaclyn Cordero is an author at AbbVie (United States) specializing in hematologic malignancy therapy, medicine, and immunotherapy.
Publications per year
2001–2018
Promising efficacy and acceptable safety of venetoclax plus bortezomib and dexamethasone in relapsed/refractory MM
Philippe Moreau, Asher Chanan‐Khan, Andrew W. Roberts et al. · Blood · 2017 · 271 citations · Full text
Medicine, Pharmacology, Pharmacotherapy +12
Venetoclax, bendamustine, and rituximab in patients with relapsed or refractory NHL: a phase Ib dose-finding study
Sven de Vos, L. J. Swinnen, Dee Dee Wang et al. · Annals of Oncology · 2018 · 72 citations · Full text
Pharmacy, Pharmacokinetics, Pharmacology +17
A Dose-Escalation Study of Venetoclax (ABT-199/GDC-0199) in Combination with Bendamustine and Rituximab in Patients with Relapsed or Refractory Non-Hodgkin's Lymphoma
Sven de Vos, Lode J. Swinnen, M. Kozloff et al. · Blood · 2015 · 35 citations
Pharmacy, Oncology, Pharmacotherapy +12
Venetoclax Combined with Bortezomib and Dexamethasone for Patients with Relapsed/Refractory Multiple Myeloma
Philippe Moreau, Asher Chanan‐Khan, Andrew W. Roberts et al. · Blood · 2016 · 23 citations
Medicine, Hematology, Pharmacotherapy +11
Phase 2 study of venetoclax plus carfilzomib and dexamethasone in patients with relapsed/refractory multiple myeloma.
Luciano J. Costa, Edward A. Stadtmauer, Gareth J. Morgan et al. · Journal of Clinical Oncology · 2018 · 21 citations
Medicine, Pharmacology, Pharmacotherapy +14
1–5 of 6